Taiwan FDA registration f654265dc64f455fa4039f4e6cb79d13
"Dieufa" pathological diagnosis of adenotumor markers with primary antibodies (unsterilized)
TW: "戴歐法"病理診斷腺腫瘤標記用一級抗體(未滅菌)
Taiwan·Risk Class 1·DIANOVA GMBH·Registered Oct 06, 2011 – Oct 06, 2021CancelledRegistration details
- Analysis ID
- f654265dc64f455fa4039f4e6cb79d13
- Customs Code
- DHA04401091305
Company information
- Manufacturer
- DIANOVA GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- BOND BIOTECH, INC.
Product details
- Intended Use
- Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.1860 Immunopathological histochemistry reagents and kits
- Import Information
- import
Dates and status
- Registration Date
- Oct 06, 2011
- Expiry Date
- Oct 06, 2021
- Cancellation Date
- Sep 08, 2023
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for "Dieufa" pathological diagnosis of adenotumor markers with primary antibodies (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number f654265dc64f455fa4039f4e6cb79d13 and manufactured by DIANOVA GMBH. The authorized representative in Taiwan is BOND BIOTECH, INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices